EPA gets six more years to study PFAS contamination in water
H.R. 6667 — PFAS Research and Development Reauthorization Act of 2025 · Filed by Chris Pappas (D-NH) · 1 cosponsor · Introduced Dec 11, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill extends EPA funding authorization for PFAS (per- and polyfluoroalkyl substances) research and development from 2024 through 2030. It does not appropriate new money — it simply extends the existing authorization window, allowing the EPA to continue spending previously authorized funds on studying and addressing PFAS contamination.
Why we flagged it
The bill's sole function is to extend an existing EPA research authorization. It is a routine reauthorization measure with no policy innovation, no new appropriation, and no private carve-out — purely procedural extension of an existing public-health research mandate.
What the text implies
- Extension does not guarantee appropriations: Congress must still fund PFAS research in annual appropriations bills. Authorization alone does not unlock money.
- PFAS research scope and priorities remain set by EPA and existing statute (7362 NDAA 2020); this bill does not change research direction or mandate new studies.
The full analysis lists 3 implications of this text.
Who it affects
PFAS contamination poses documented public-health risks (groundwater, drinking water, bioaccumulation). Extending research authorization allows the EPA to continue studying remediation, health effects, and detection methods — work that directly informs regulatory and cleanup decisions affecting ordinary people's water safety and environmental health.